Literature DB >> 1376109

Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement.

T R Hughes1, S J Piddlesden, J D Williams, R A Harrison, B P Morgan.   

Abstract

The membrane attack complex (MAC) of complement in humans is regulated by several membrane-bound proteins; however, no such proteins have so far been described in other species. Here we report the isolation and characterization of a rat erythrocyte membrane glycoprotein of molecular mass 21 kDa which inserts into cell membranes and is a potent inhibitor of the rat MAC. This protein, here called rat inhibitory protein (RIP), was first partially purified by column chromatography from a butanol extract of rat erythrocyte membranes. Monoclonal antibodies (Mabs) were raised against RIP and used for its affinity purification. Affinity-purified RIP was shown to inhibit in a dose-dependent manner the cobra venom factor (CVF)-mediated 'reactive' lysis of guinea pig erythrocytes by rat complement. Conversely, the anti-RIP MAbs 6D1 and TH9 were shown to markedly enhance the CVF-mediated lysis of rat erythrocytes by rat complement. RIP acted late in the assembly of the MAC (at or after the C5b-8 stage) and was releasable from the membranes of rat erythrocytes by phosphatidylinositol-specific phospholipase C. These features, together with its size, deglycosylation pattern and N-terminal amino acid sequence, lead us to conclude that RIP is the rat homologue of the human MAC-inhibitory protein CD59 antigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376109      PMCID: PMC1132712          DOI: 10.1042/bj2840169

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  Ly-6: a multigene family in search of a function.

Authors:  E M Shevach; P E Korty
Journal:  Immunol Today       Date:  1989-06

Review 2.  Heymann nephritis: mechanisms of renal injury.

Authors:  D J Salant; R J Quigg; A V Cybulsky
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

3.  Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.

Authors:  L S Zalman; M A Brothers; H J Müller-Eberhard
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

4.  Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L R Fredrick; N J Bernshaw; L A Wilcox; C J Parker
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Human leukocyte differentiation antigens.

Authors:  A Bernard; V Horejsi
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

6.  Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol.

Authors:  I Stefanová; I Hilgert; H Kristofová; R Brown; M G Low; V Horejsí
Journal:  Mol Immunol       Date:  1989-02       Impact factor: 4.407

7.  Lipid analysis of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase. Palmitoylation of inositol results in resistance to phosphatidylinositol-specific phospholipase C.

Authors:  W L Roberts; J J Myher; A Kuksis; M G Low; T L Rosenberry
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

8.  Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement.

Authors:  Y Sugita; T Tobe; E Oda; M Tomita; K Yasukawa; N Yamaji; T Takemoto; K Furuichi; M Takayama; S Yano
Journal:  J Biochem       Date:  1989-10       Impact factor: 3.387

9.  A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

Authors:  N Okada; R Harada; T Fujita; H Okada
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

10.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Authors:  A Davies; D L Simmons; G Hale; R A Harrison; H Tighe; P J Lachmann; H Waldmann
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  30 in total

1.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

Authors:  R J Quigg; C He; B K Hack; J J Alexander; B P Morgan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

3.  Interaction between host complement and mosquito-midgut-stage Plasmodium berghei.

Authors:  G Margos; S Navarette; G Butcher; A Davies; C Willers; R E Sinden; P J Lachmann
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.

Authors:  M Mizuno; K Nishikawa; B P Morgan; S Matsuo
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

5.  Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.

Authors:  N K Rushmere; R A Harrison; C W van den Berg; B P Morgan
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 6.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

7.  Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.

Authors:  J Yu; T Caragine; S Chen; B P Morgan; A B Frey; S Tomlinson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

8.  The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

Authors:  C W van den Berg; R A Harrison; B P Morgan
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

9.  Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.

Authors:  A Nomura; K Nishikawa; Y Yuzawa; H Okada; N Okada; B P Morgan; S J Piddlesden; M Nadai; T Hasegawa; S Matsuo
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies.

Authors:  S M Hanna; G T Williams; C W Van Den Berg; B P Morgan
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.